Evidence map›Paper›PMID 20139098›Full record

ArticleBlood2010

Latent herpesvirus infection arms NK cells.

Douglas W White, Catherine R Keppel, Stephanie E Schneider, Tiffany A Reese, James Coder, Jacqueline E Payton, Timothy J Ley, Herbert W Virgin, Todd A Fehniger

Open access · greenAbstract read
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Altered CD4Clinical and experimental immunology · 2018
    Article
  14. The Intestinal Virome and Immunity.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Review
  15. Review
  16. Marek's disease vaccine activates chicken macrophages.Journal of veterinary science · 2018
    Article
  17. Review
  18. Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?Frontiers in cellular and infection microbiology · 2018
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Douglas W WhiteDivision of Rheumatology, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Catherine R Keppel
Stephanie E Schneider
Tiffany A Reese
James Coder
Jacqueline E Payton
Timothy J Ley
Herbert W Virgin
Todd A Fehniger
Washington University in St. Louis · USCenter for Rheumatology · US

Funding

Virology and Smallpox VaccinationsU54AI057160 · NIAID · WASHINGTON UNIVERSITY · PI OLDSTONE, MICHAEL B · 2003 to 2013
$80.9M
THE ROLE OF GRANZYMES IN CYTOTOXIC LYMPHOCYTE FUNCTIONSR01DK049786 · NIDDK · WASHINGTON UNIVERSITY · PI LEY, TIMOTHY J. · 1995 to 2009
$3.5M
Regulation of Y-herpesvirus latency and tumorigenesisR01CA074730 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 1998 to 2007
$2.8M
T Cell Vaccination Against gamma-herpesvirus LatencyR01CA096511 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 2002 to 2012
$2.4M
Molecular Mechanisms of Natural Killer Cell Cytokine-ActivationK08HL093299 · NHLBI · WASHINGTON UNIVERSITY · PI FEHNIGER, TODD A · 2009 to 2013
$583k
Molecular mechanisms of gammaherpesvirus latency and reactivationK08AI079011 · NIAID · WASHINGTON UNIVERSITY · PI WHITE, DOUGLAS W. · 2008 to 2009
$113k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA074730NCI NIH HHS R01CA074730NCI NIH HHS R01 CA096511NCI NIH HHS R01CA096511NHLBI NIH HHS K08 HL093299NHLBI NIH HHS K08HL093299NIAID NIH HHS K08 AI079011NIAID NIH HHS K08AI079011NIAID NIH HHS U54 AI057160NIDDK NIH HHS R01 DK049786NIDDK NIH HHS R01DK49786
6 · The paper itself

Abstract

Natural killer (NK) cells were identified by their ability to kill target cells without previous sensitization. However, without an antecedent "arming" event, NK cells can recognize, but are not equipped to kill, target cells. How NK cells become armed in vivo in healthy hosts is unclear. Because latent herpesviruses are highly prevalent and alter multiple aspects of host immunity, we hypothesized that latent herpesvirus infection would arm NK cells. Here we show that NK cells from mice latently infected with Murid herpesvirus 4 (MuHV-4) were armed as evidenced by increased granzyme B protein expression, cytotoxicity, and interferon-gamma production. NK-cell arming occurred rapidly in the latently infected host and did not require acute viral infection. Furthermore, NK cells armed by latent infection protected the host against a lethal lymphoma challenge. Thus, the immune environment created by latent herpesvirus infection provides a mechanism whereby host NK-cell function is enhanced in vivo.

Indexed as

RhadinovirusAnimalsCell DegranulationCytotoxicity, ImmunologicGenes, RAG-1GranzymesHerpesviridae InfectionsInterferon-gammaKiller Cells, NaturalMiceMice, Inbred C57BLMice, KnockoutTumor Virus InfectionsGranzymesInterferon-gamma

Identifiers

PMID20139098
PMCPMC2881492
OpenAlexW1991366046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.